Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2020.7554
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Triple-Negative Breast Cancer

2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)

Case Reports in Oncological Medicine
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy